| Date Filed | Type | Description |
| 06/16/2023 |
4
| Young Matthew P. (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.57, valued at
$39.3k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
4
| Young Matthew P. (Director) has filed a Form 4 on PRA Health Sciences, Inc.|
Txns:
| Disposed/sold 7,127 shares
@ $0 |
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Young Matthew P. (Director) has filed a Form 4 on PRA Health Sciences, Inc.|
Txns:
| Granted 250 shares
@ $0 |
|
| 06/17/2020 |
4
| Young Matthew P. (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $8.35, valued at
$167k
|
|
| 05/20/2020 |
4
| Young Matthew P. (Director) has filed a Form 4 on PRA Health Sciences, Inc.|
Txns:
| Granted 1,324 shares
@ $0 |
|
| 06/21/2019 |
4
| Young Matthew P. (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 14,000 options to buy
@ $11.31, valued at
$158.3k
|
|
| 06/05/2019 |
4
| Young Matthew P. (Director) has filed a Form 4 on PRA Health Sciences, Inc.|
Txns:
| Granted 1,436 shares
@ $0 |
|
| 03/07/2019 |
4
| Young Matthew P. (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 1,267 shares
@ $135.82, valued at
$172.1k
Paid exercise price by delivering 1,348 shares
@ $135.82, valued at
$183.1k
Sold 1,152 shares
@ $135.41, valued at
$156k
|
|
| 03/04/2019 |
4
| Young Matthew P. (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 12,000 shares
@ $0
Granted 714 options to buy
@ $140.03, valued at
$100k
Granted 29,286 options to buy
@ $140.03, valued at
$4.1M
|
|
| 02/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/27/2018 |
4
| Young Matthew P. (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 700 shares
@ $150, valued at
$105k
|
|
| 10/17/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2018 |
4
| Young Matthew P. (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 700 shares
@ $162.7, valued at
$113.9k
|
|
| 08/16/2018 |
4
| Young Matthew P. (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 700 shares
@ $176.05, valued at
$123.2k
|
|
| 07/18/2018 |
4
| Young Matthew P. (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 700 shares
@ $176.06, valued at
$123.2k
|
|
| 06/25/2018 |
4
| Young Matthew P. (Director) has filed a Form 4 on PRA Health Sciences, Inc.|
Txns:
| Granted 1,307 shares
@ $0 |
|
| 06/19/2018 |
4
| Young Matthew P. (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 700 shares
@ $176.99, valued at
$123.9k
|
|
| 06/15/2018 |
4
| Young Matthew P. (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 14,000 options to buy
@ $25.25, valued at
$353.5k
|
|
| 06/05/2018 |
4
| Young Matthew P. (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 5,000 shares
@ $170.0424, valued at
$850.2k
Exercised 5,000 options to buy
@ $58.72, valued at
$293.6k
|
|
| 05/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2018 |
4
| Young Matthew P. (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 700 shares
@ $156.01, valued at
$109.2k
|
|
| 03/19/2018 |
4
| Young Matthew P. (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 700 shares
@ $151.22, valued at
$105.9k
|
|
| 03/07/2018 |
4
| Young Matthew P. (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 1,348 shares
@ $143.39, valued at
$193.3k
Sold 800 shares
@ $142.06, valued at
$113.6k
Sold 352 shares
@ $143.0406, valued at
$50.4k
|
|
| 03/05/2018 |
4
| Young Matthew P. (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 9,400 shares
@ $0
Granted 710 options to buy
@ $140.67, valued at
$99.9k
Granted 22,790 options to buy
@ $140.67, valued at
$3.2M
|
|
| 02/28/2018 |
4
| Young Matthew P. (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 2,253 shares
@ $147.44, valued at
$332.2k
Sold 1,016 shares
@ $144.961, valued at
$147.3k
Sold 600 shares
@ $145.8333, valued at
$87.5k
Sold 300 shares
@ $147.2967, valued at
$44.2k
Paid exercise price by delivering 606 shares
@ $143.8, valued at
$87.1k
Sold 200 shares
@ $145.245, valued at
$29k
Sold 119 shares
@ $147.5561, valued at
$17.6k
Sold 200 shares
@ $149.015, valued at
$29.8k
Sold 700 shares
@ $150, valued at
$105k
|
|
| 01/18/2018 |
4
| Young Matthew P. (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 700 shares
@ $152.16, valued at
$106.5k
|
|
| 11/17/2017 |
4
| Young Matthew P. (Director) has filed a Form 4 on PRA Health Sciences, Inc.|
Txns:
| Gifted 5,115 shares
@ $0
Gifted 5,115 shares
@ $0
Sold 5,115 shares
@ $79.9, valued at
$408.7k
|
|
| 07/14/2017 |
4
| Young Matthew P. (Director) has filed a Form 4 on PRA Health Sciences, Inc.|
Txns:
| Granted 1,318 shares
@ $0 |
|
| 06/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|